Platomics

Private

ViennaHealthcare & Life Scienceshttps://platomics.com/

Last Round

Series A

Sep 20, 2021

Total Funding Raised

$16.38M

Company Overview

Platomics is a healthtech company that provides a platform for regulatory automation for in vitro diagnostics, connecting manufacturers, labs, and regulators.

Sector

Healthcare & Life Sciences

Verticals

RegTech, Compliance, Vertical SaaS, Workflow Automation, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Services & Consulting

AI Layer

Application

Keywords

regulatory automationIVDR compliancein-vitro diagnosticsIVDRegTechcompliance automationIn Vitro Diagnostic RegulationIVDRlab-developed testsLDTsregulatory documentationMedTech complianceclinical laboratory softwareVertical SaaSworkflow automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Platomics Comps

Public and private peers based on sector, stage, and business model.

Platomics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Platomics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Sep 20, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Kriegner Albert

CEO

Executive Team

Rodrigo Berlie

CEO and Managing Director

Executive Team

Felix Kamml

Chief Financial Officer

Executive Team

Piotr Gawel

Chief Operating Officer

Executive Team

View all key people

Platomics Investors

Notable investors and investment history

Platomics investors
Investor	Rounds
GreyBird Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 14, 2023
Grew 17% QoQ, from 70 to 82 employees.

View all signals

Platomics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Platomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Platomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna

Employee Range66

Year Founded2014

Last FundingSep 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.